Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy.

Freddy CalderaStacey RolakFrancis A FarrayeBrian M NecelaDavitte CogenEmily E ZonaTrevor L SchellOscar Ramirez RamirezMazen AlmasryKelly ChunMary S HayneyKeith L Knutson

Published in: Clinical and translational gastroenterology (2024)

A third dose of a COVID-19 vaccine boosts CMIR, and the response is sustained in patients with IBD.

Keyphrases

coronavirus disease
patients with inflammatory bowel disease
sars cov
immune response
rheumatoid arthritis
single cell
cell therapy
respiratory syndrome coronavirus
dendritic cells
bone marrow
binding protein
ulcerative colitis